Hints and tips:
Related Special Reports
...John Jacobs told the Financial Times there was no guarantee governments would deliver on all their existing commitments with the company, which include $2.1bn in advanced purchase agreements signed with...
...(Pimco) — The PagerDuty CEO who quoted Martin Luther King in her mass sacking email is v v v sorry....
...john.gapper@ft.com...
...Job moves JPMorgan Chase has hired John China — the president of Silicon Valley Bank’s venture capital arm SVB Capital — as co-head of innovation economy based in San Francisco....
...Novavax’s Stanley Erck will be replaced by John C Jacobs, most recently chief executive at Harmony Biosciences, this month; CureVac’s Franz-Werner Haas will be succeeded by Alexander Zehnder, a Sanofi veteran...
...Olivia V, a video editor living in Toronto, started the @indiesleaze Instagram account because she felt it was a decade “not yet neatly defined or revisited”....
...Go plain and neat (even John Lewis has a good one!) and relish the cosy hug they give you....
...David Dowdy, an epidemiologist at Johns Hopkins School of Medicine, said the delay made sense given that case rates in the US are declining rapidly and that new data on a three-dose regimen should be available...
...Amesh Adalja, an infectious disease specialist at Johns Hopkins Center for Health Security, said it would have been better to have an Omicron-based version of the vaccine before the variant surged....
...ExxonMobil’s stock market recovery first began when Pfizer et al announced that they had developed a strong slate of anti-Covid vaccines in November 2020....
...Two doses of the BioNTech/Pfizer vaccine provide 70 per cent protection against being admitted to hospital with the Omicron coronavirus variant, according to the first real-world analysis of protection against...
...“Thanks to their hard work, we achieved a vaccine in record time and currently have multiple vaccines available — enough to reach every corner of the globe,” said John Murphy, chief policy officer at Bio...
...It was written in 1964 in the George V luxury hotel in Paris, a city to which McCartney and Lennon had hitchhiked only a few years previously. What money could buy was at the forefront of their minds....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...As they conceived the film they were inspired by William Friedkin’s 1971 classic The French Connection, the work of John Frankenheimer and Die Hard director John McTiernan....
...Additional reporting by John Burn-Murdoch in London...
...However, it remains to be seen how long a booster can protect for, when “antibody levels wax and wane”, said Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security....
...vaccinated and there is not enough vaccine uptake in the population above 12 years [of age] to prevent cases recognised in schools from disrupting in-person learning,” said Amesh Adalja, a senior scholar at the Johns...
...John Trizzino, chief commercial officer at Novavax, reminded a conference recently. “It’s a good vaccine,” he generously said of Pfizer and Moderna’s efforts, “but there’s a need for our vaccine.”...
...However, Ugur Sahin, head of BioNTech, who developed the vaccine now produced by Pfizer, struck a more positive note....
...Paul Hunter, an infectious disease expert at the University of East Anglia, warned about relying too heavily on studies that could just be “random fluke”....
...David Dowdy, an epidemiologist at Johns Hopkins School of Medicine, said the number one message is that existing data showed that all of the widely used vaccines are exceptionally safe....
...There’s nothing gonna be like John Kelly in a second Trump term....
...New York Fed president John Williams will participate in a discussion hosted by The New York Times on “Health and the Economy.”...
...The makers of Russia’s Sputnik V have said it was “more efficient against the Delta variant of coronavirus . . . than any other vaccine that published results on this strain so far”, but provided no evidence...
International Edition